Pennsylvania news: Personalized treatment for deadly blood and bone marrow cancer
WFMZ-TV in Allentown, Pennsylvania recently highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
“Although it has one name there are probably 15, 20 different types of AML. Before, when people were diagnosed with AML, they would come in and everybody would be treated the same way,” said Byrd, MD, a University of Cincinnati Cancer Center researcher, chair of the Department of Internal Medicine at the UC College of Medicine and the chief medical officer of the Beat AML study.
Using genetic sequencing, researchers are identifying what drives each patient's disease and personalizing treatments accordingly.
“Once a medicine gets approved in one indication, it can potentially be applied to a lot of other types of cancers that have that same mutation, but might be in a different part of the body,” Byrd said.
The Beat AML trial is unique because it a master trial studying multiple drugs at the same time.
Featured photo at top of Erin Hertlein, PhD, left, and John Byrd, MD, working in the lab. Photo/UC Foundation.
Related Stories
Love it or raze it?
February 20, 2026
An architectural magazine covered the demolition of UC's Crosley Tower.
Social media linked to student loneliness
February 20, 2026
Inside Higher Education highlighted a new study by the University of Cincinnati that found that college students across the country who spent more time on social media reported feeling more loneliness.
Before the medals: The science behind training for freezing mountain air
February 19, 2026
From freezing temperatures to thin mountain air, University of Cincinnati exercise physiologist Christopher Kotarsky, PhD, explained how cold and altitude impact Olympic performance in a recent WLWT-TV/Ch. 5 news report.